Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CHC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Active Not RecruitingNCT03520660
What this trial is testing

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

Who this might be right for
Diabetes MellitusHepatitis C, ChronicCardiovascular Diseases
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 121
Post-approval studies (Phase 4)UnknownNCT01597934
What this trial is testing

Antiviral Efficacy of Switching to ETV Plus TDF

Who this might be right for
Chronic Hepatitis B
Yonsei University 104
Not applicableStudy completedNCT02084498
What this trial is testing

Advanced Carbohydrate Counting and Automated Bolus Calculation

Who this might be right for
Type 1 Diabetes
Steno Diabetes Center Copenhagen 178
Not applicableStudy completedNCT03868163
What this trial is testing

Real World Evidence of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C in the Russian Federation

Who this might be right for
Chronic Hepatitis C (CHC)
AbbVie 161
Post-approval studies (Phase 4)Study completedNCT00412334
What this trial is testing

SYREN Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Non-Responder Patients With Chronic Hepatitis C (CHC) Genotype 1.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 104
Testing effectiveness (Phase 2)Study completedNCT01842451
What this trial is testing

Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-135 and Daclatasvir in Subjects With Genotype 1 Chronic Hepatitis C Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis CCHCHCV+1 more
Vertex Pharmaceuticals Incorporated 23
Not applicableStudy completedNCT00923559
What this trial is testing

Mother-Infant Psychoanalysis Project of Stockholm

Who this might be right for
Mother-infant Relational Disturbances
Karolinska Institutet 80
Not applicableStudy completedNCT01609049
What this trial is testing

An Observational Study of Peginterferon Alfa-2a in Combination With Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,496
Not applicableEnded earlyNCT01100749
What this trial is testing

Chronic Hepatitis C (CHC) - Genotype 3 Infection in Canada

Who this might be right for
Chronic Hepatitis C - Genotype 3
University Health Network, Toronto 25
Not applicableStudy completedNCT00687999
What this trial is testing

NIDDM and IR in Combination Therapy for CHC

Who this might be right for
Chronic Hepatitis CInsulin Resistance
Kaohsiung Medical University Chung-Ho Memorial Hospital 400
Not applicableUnknownNCT04405011
What this trial is testing

NUC in Preventing HBV Reactivation in HCV/HBV Co-infected Patients Receiving DAA for CHC

Who this might be right for
HBV/HCV Co-infection
National Taiwan University Hospital 60
Not applicableUnknownNCT06481449
What this trial is testing

Definitive Radiotherapy for Cervical and Upper Thoracic Esophageal Cancer (ChC&UES): A Multi-center Real World Study

Who this might be right for
Esophageal Neoplasm
Hebei Medical University Fourth Hospital 2,600
Not applicableUnknownNCT03510637
What this trial is testing

"Real Life" Evaluation of Efficacy and Safety of Direct Antiviral Agents (DAAs) for the Treatment of Hepatitis C Virus in Egypt

Who this might be right for
Chronic Hepatitis C
ANRS, Emerging Infectious Diseases 7,500
Post-approval studies (Phase 4)Study completedNCT00192647
What this trial is testing

Induction Dosing With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C (CHC) Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 896
Not applicableUnknownNCT00188240
What this trial is testing

Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral Therapy

Who this might be right for
Hepatitis CHepatitis B
University Health Network, Toronto 200
Testing effectiveness (Phase 2)Study completedNCT03020004
What this trial is testing

Efficacy and Safety of Danoprevir/r + PR 12-week Triple Therapy in Treatment-Naive, Non-Cirrhotic, G1 CHC China II

Who this might be right for
Chronic Hepatitis C
Ascletis Pharmaceuticals Co., Ltd. 70
Large-scale testing (Phase 3)Study completedNCT01753557
What this trial is testing

Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis C

Who this might be right for
Chronic Hepatitis C (CHC)
Tanabe Pharma Corporation 54
Not applicableStudy completedNCT02057952
What this trial is testing

HealthyMe Online Weight Management Education/HealthyMe at Home

Who this might be right for
Diabetes
Indiana University 150
Large-scale testing (Phase 3)Study completedNCT01753570
What this trial is testing

Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C (CHC)

Who this might be right for
Chronic Hepatitis C(CHC)
Tanabe Pharma Corporation 74
Not applicableEnded earlyNCT03500562
What this trial is testing

Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 3
Next Page